Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer
Background/Aims: Treatment of breast cancer remains a clinical challenge. This study aims to validate exosomal microRNA-1246 (miR-1246) as a serum biomarker for breast cancer and understand the underlying mechanism in breast cancer progression. Methods: The expression levels of endogenous and exosom...
Main Authors: | Xiu Juan Li, Zhao Jun Ren, Jin Hai Tang, Qiao Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-12-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/485780 |
Similar Items
-
miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
by: Shih-Shen Lin, et al.
Published: (2018-08-01) -
MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma
by: Chen Dai, et al.
Published: (2020-03-01) -
Phenformin suppresses angiogenesis through the regulation of exosomal microRNA-1246 and microRNA-205 levels derived from oral squamous cell carcinoma cells
by: Dexuan Zhuang, et al.
Published: (2022-09-01) -
A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers
by: Soudeh Ghafouri-Fard, et al.
Published: (2022-01-01) -
5′-Isoforms of miR-1246 Have Distinct Targets and Stronger Functional Impact Compared with Canonical miR-1246 in Colorectal Cancer Cells In Vitro
by: Rokas Lukosevicius, et al.
Published: (2024-02-01)